Trubion Pharmaceuticals' IPO

Trubion Pharmaceuticals raised a round of funding on October 18, 2006. Investors include Public.

Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer. The Company's product candidates are novel proteins known as si…

Articles about Trubion Pharmaceuticals' IPO: